Skip to main content
. Author manuscript; available in PMC: 2014 May 5.
Published in final edited form as: Cancer Control. 2012 Oct;19(4):255–266. doi: 10.1177/107327481201900402

Table 3.

Basic Elements of Informed Consent for Cancer Susceptibility Testing

  1. Information on the specific test being performed

  2. Implications of a positive and negative result

  3. Possibility that the test will not be informative

  4. Options for risk estimation without genetic testing

  5. Risk of passing a mutation to children

  6. Technical accuracy of the test

  7. Fees involved in testing and counseling

  8. Psychological implications of tests results (benefits and risks)

  9. Risks and protections against genetic discrimination by employers or insurers

  10. Confidentiality issues

  11. Options and limitations of medical surveillance and strategies for prevention following testing

  12. Importance of sharing genetic test results with at-risk relatives so that they may benefit from this information

From American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21(12):2397–2406. Reprinted with permission. © 2003 American Society of Clinical Oncology. All rights reserved.